A randomized two-sided placebo-controlled study on the efficacy and safety of atmospheric non-thermal argon plasma for pruritus

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 3, 2013, Pages 324-331

  Heinlin, J ^a   Isbary, G ^b   Stolz, W ^b   Zeman, F ^a   Landthaler, M ^a   Morfill, G ^c   Shimizu, T ^c   Zimmermann, J L ^c   Karrer, S ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Klinikum Schwabing   (Germany)

^c MAX PLANCK INSTITUT FÜR EXTRATERRESTRISCHE PHYSIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; CAPSAICIN; GLUCOCORTICOID; ICHTHAMMOL; NEUROLEPTIC AGENT; PERMETHRIN; PLACEBO; POLIDOCANOL;

ADULT; AGED; ARGON PLASMA COAGULATION; ARTICLE; CLINICAL EFFECTIVENESS; COLD ARGON PLASMA TREATMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEAT SENSATION; HUMAN; MALE; MEDICAL DEVICE; MICROWAVE IRRADIATION; PATIENT SAFETY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE; SKIN BURNING SENSATION; SKIN TIGHTNESS; SKIN TINGLING; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ARGON; ATMOSPHERE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PLASMA GASES; PROSPECTIVE STUDIES; PRURITUS; VISUAL ANALOG SCALE;

EID: 84874112887     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04395.x     Document Type: Article

References (37)

1. Heinlin J, Isbary G, Stolz W, et al. Plasma applications in medicine with a special focus on dermatology. J Eur Acad Dermatol Venereol 2011; 25: 1-11.
2. Isbary G, Morfill G, Schmidt HU, et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol 2010; 163: 78-82.
3. Mertens N, Helmke A, Vioel W,. Dielectric barrier discharge plasma-an upcoming approach in skin treatment. In: 2nd International Workshop on Plasma-Tissue Interactions. Greifswald, Germany. 2009.
4. Sommer F, Hensen P, Bockenholt B, et al. Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol 2007; 87: 510-516.
5. Zirwas MJ, Seraly MP,. Pruritus of unknown origin: a retrospective study. J Am Acad Dermatol 2001; 45: 892-896.
6. Stander S, Weisshaar E, Steinhof M, et al. [Pruritus-pathophysiology, clinical features and therapy-an overview]. J Dtsch Dermatol Ges 2003; 1: 105-118.
7. Blome C, Augustin M, Siepmann D, et al. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 2009; 161: 1143-1148.
8. Pogatzki-Zahn E, Marziniak M, Schneider G, et al. Chronic pruritus: targets, mechanisms and future therapies. Drug News Perspect 2008; 21: 541-551.
9. Dalgard F, Svensson A, Holm JO, et al. Self-reported skin morbidity in Oslo. Associations with sociodemographic factors among adults in a cross-sectional study. Br J Dermatol 2004; 151: 452-457.
10. Yosipovitch G, David M,. The diagnostic and therapeutic approach to idiopathic generalized pruritus. Int J Dermatol 1999; 38: 881-887.
11. Gupta MA, Gupta AK,. Depression modulates pruritus perception. A study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria. Ann NY Acad Sci 1999; 885: 394-395.
12. Paus R, Schmelz M, Biro T, et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 2006; 116: 1174-1186.
13. Verhoeven EW, de Klerk S, Kraaimaat FW, et al. Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review. Acta Derm Venereol 2008; 88: 211-218.
14. Buske-Kirschbaum A, Geiben A, Hellhammer D,. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 2001; 70: 6-16.
15. Kodama A, Horikawa T, Suzuki T, et al. Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol 1999; 104: 173-176.
16. Ward L, Wright E, McMahon SB,. A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain. Pain 1996; 64: 129-138.
17. Nilsson HJ, Levinsson A, Schouenborg J,. Cutaneous field stimulation (CFS): a new powerful method to combat itch. Pain 1997; 71: 49-55.
18. Nilsson HJ, Psouni E, Carstam R, et al. Profound inhibition of chronic itch induced by stimulation of thin cutaneous nerve fibres. J Eur Acad Dermatol Venereol 2004; 18: 37-43.
19. Stander S, Streit M, Darsow U, et al. [Diagnostic and therapeutic procedures in chronic pruritus]. J Dtsch Dermatol Ges 2006; 4: 350-370.
20. Kronauer C, Eberlein-Konig B, Ring J, et al. Influence of UVB, UVA and UVA1 irradiation on histamine release from human basophils and mast cells in vitro in the presence and absence of antioxidants. Photochem Photobiol 2003; 77: 531-534.
21. Gilchrest BA, Rowe JW, Brown RS, et al. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med 1979; 91: 17-21.
22. Lademann J, Richter H, Alborova A, et al. Risk assessment of the application of a plasma jet in dermatology. J Biomed Opt 2009; 14: 054025.
23. Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-760.
24. Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006; 117: 411-417.
25. Zampeli E, Tiligada E,. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009; 157: 24-33.
26. Yamaura K, Oda M, Suwa E, et al. Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J Toxicol Sci 2009; 34: 427-431.
27. Costa SK, Starr A, Hyslop S, et al. How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom. Vascul Pharmacol 2006; 45: 209-214.
28. Mertens N, Helmke A, Goppold A, et al. Low temperature plasma treatment of human tissue. In: Second International Conference on Plasma Medicine. San Antonio, Texas, USA. 2009.
29. Heinlin J, Morfill G, Landthaler M, et al. Plasma medicine: possible applications in dermatology. J Dtsch Dermatol Ges 2010; 8: 968-976.
30. Daeschlein G, Darm K, Majunke S, et al. In vivo monitoring of atmospheric pressure plasma jet (APPJ) skin therapy by confocal laserscan microscopy (CLSM). In: Second International Conference on Plasma Medicine. San Antonio, Texas, USA. 2009.
31. Wende K, Landsberg K, Lindequist U, et al. Microorganisms, human cells and cold atmospheric plasma-looking for an intersection. In: 2nd International Workshop on Plasma-Tissue Interactions. Greifswald, Germany. 2009.
32. Sosnin EA, Stoffels E, Erofeev MV, et al. The effects of UV irradiation and gas plasma treatment on living mammalian cells and bacteria: a comparative approach. IEEE Transact Plasma Sci 2004; 32: 1544-1550.
33. Pompl R, Shimizu T, Schmidt HU, et al. Efficiency and medical compatibility of low-temperature plasma sterilization. In: 6th International Conference on Reactive Plasmas. Matsushima, Japan. 2006.
34. Fridman G, Friedman G, Gutsol A, et al. Applied plasma medicine. Plasma Process Polym 2008; 5: 503-533.
35. Dobrynin D, Fridman G, Friedman G, et al. Physical and biological mechanisms of direct plasma interaction with living tissue. New J Phys 2009; 11: 115020.
36. Nosenko T, Shimizu T, Morfill GE,. Designing plasmas for chronic wound disinfection. New J Phys 2009; 11: 115013.
37. Kramer A, Hübner N-O, Assadian O, et al. Chances and perspectives of the plasma medicine by use of tissue tolerable plasmas (TTP). GMS Krankenhaushygiene interdisziplinär 2009; 4: 1-5.